Prediction of left ventricular mass changes after renal transplantation by polymorphism of the angiotensin-converting-enzyme gene

Kidney International

Volumn 51, Issue 4, 1997, Pages 1205-1211

  Hernández, Domingo ^a,b   Lacalzada, Juan ^a   Rufino, Margarita ^a   Torres, Armando ^a   Martín, Natalia ^a   Barragán, Antonio ^a   Barrios, Ysamar ^a   Macía, Manuel ^a   De Bonis, Eduardo ^a   Lorenzo, Víctor ^a   Rodríguez, Aurelio ^a   González Posada, Jose Manuel ^a   Salido, Eduardo ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Urbanización El Gramal   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE; LYMPHOBLAST ANTIBODY; METHYLPREDNISOLONE; OKT 3; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 8244225993     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.164     Document Type: Article

References (45)

1. FIRST MR: Long-term complications after transplantation. Am J Kidney Dis 22:477-486, 1993
2. KASISKE BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84:985-992, 1988
3. KASISKE BL: Risk factors for cardiovascular disease after renal transplantation. Miner Electrol Metab 19:186-195, 1993
4. LEVY D, GARRISON RJ, SAVAGE DD, KANNEL WB, CASTELLI WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990
5. LONDON GM, MARCHAIS SJ, GUERIN AP, METIVIER F, PANNIER B: Cardiac hypertrophy and arterial alterations in end-stage renal disease: Hemodynamic factors. Kidney Int 43(Suppl 41):S42-S49, 1993
6. FOLEY RN, PARFREY PS, HARNETT JD, KENT GM, MARTIN CJ, MURRAY DC, BARRE PE: Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47:186-192, 1995
7. SILBERBERG JS, BARRE PE, PRICHARD SS, SNIDERMAN AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36:286-290, 1989
8. IKÄHEIMO M, LINNALUOTO M, HUTTUNEN K, TAKKUNEN J: Effects of renal transplantation on left ventricular size and function. Br Heart J 47:155-160, 1982
9. CUETO-GARCÍA L, HERRERA J, ARRIAGA J, LAREDO C, MEANEY E: Echocardiographic changes after successful renal transplantation in young nondiabetic patients. Chest 83:56-62, 1983
10. TERUEL JL, RODRIGUEZ PADIAL L, QUEREDA C, YUSTE P, MARCEN R, ORTUÑO J: Regression of left ventricular hypertrophy after renal transplantation. A prospective study. Transplantation 43:307-309, 1987
11. PETEIRO J, ALVAREZ N, CALVINO R, PENAS M, RIBERA F, BEIRAS AC: Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: An echocardiographic and pulsed Doppler study. Cardiology 85:273-283, 1994
12. LAI KN, BARNDEN L, MATHEW TH: Effect of renal transplantation on left venticular function in hemodialysis patients. Clin Nephrol 18:74-78, 1982
13. HÜTING J: Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol 70:1481-1484, 1992
14. SADOSHIMA J-I, IZUMO S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocites and hyperplasia of cardiac fibroblasts: Critical role of the AT1 receptor subtype. Circ Res 73:413-423, 1993
15. BRILLA CG, ZHOU G, MATSUBARA L, WEBER KT: Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone. J Mol Cell Cardiol 26:809-820, 1994
16. LINDPAINTNER K, GANTEN D: The cardiac renin-angiotensin system: An appraisal of present experimental and clinical evidence. Circ Res 68:905-921, 1991
17. SOUBRIER F, ALHENC-GELAS F, HUBERT C, ALLEGRINI J, JOHN M, TREGEAR G, CORVOL P: Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390, 1988
18. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
19. SCHUNKERT H, HENSE H-W, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GAJ: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
20. MARIAN AJ, YU Q-T, WORKMAN R, GREVE G, ROBERTS R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086, 1993
21. RAYNOLDS MV, BRISTOW MR, BUSH EW, ABRAHAM WT, LOWES BD, ZISMAN LS, TAFT CS, PERRYMAN MB: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075, 1993
22. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU J-P, ARVEILER D, LUC G, BARD J-M, BARA L, RICARD S, TIRET L, AMOUYEL P, ALHENC-GELAS F, SOUBRIER F: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
23. GONZÁLEZ-POSADA JM, GARCÍA CASTRO MC, LOSADA M, LORENZO V, TORRES A, HERNÁNDEZ D, MACEIRA B, SALIDO E: Monoclonal analysis of fine-needle aspiration biopsy in kidney allografts. Nephrol Dial Transplant 5:226-231, 1990
24. KOREN MJ, DEVEREUX RB, CASALE PN, SAVAGE DD, LARAGH JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352, 1991
25. DEVEREUX R, REICHEK N: Echocardiogrphic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55:613-618, 1977
26. KRUMHOLZ HM, LARSON M, LEVY D: Prognosis of left ventricular geometric patterns in the Framingham heart study. J Am Coll Cardiol 25:879-884, 1995
27. TEICHHOLTZ L, KREULEN T, HERMAN M, GONLIN R: Problems in echocardiographic angiographic correlations in the presence or absence of asynergy. Am J Cardiol 37:7-11, 1976
28. LINDPAINTER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GRODSTEIN F, LAMOTTE F, BURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
29. DAVIS LG, DIBNER MD, BATTEY JF: Basic Methods in Molecular Biology. New York, Elsevier, 1986, pp 44-46
30. LARSSON O, WIKSTRAND J, ATTMAN P-O, WALLENTIN Y: Left ventricular function before and after renal transplantation in diabetics. Transplant Proc 16:645-648, 1984
31. ADAMS TD, YANOWITZ FG, FISHER ASG, RIDGES JD, NELSON AG, HAGAN AD, WILLIAMS RR, HUNT SC: Heritability of cardiac size: An echocardiographic and electrocardiographic study of monozygotic and dizygotic twins. Circulation 71:39-44, 1985
32. VERHAAREN HA, SCHIEKEN RM, MOSTELLER M, HEWITT JK, EAVES LJ, NANCE WE: Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol 68:661-668, 1991
33. NAFTILAN AJ, PRATT RE, DZAU VJ: Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-1424, 1989
34. FARHY RD, HO KL, CARRETERO OA, SCICLI AG: Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Comun 182:283-288, 1992
35. SCHUNKERT H, DZAU VJ, TANG SS, HIRSCH AT, APSTEIN CS, LORELL BH: Increase rat cardiac angiotrensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistence, contractily and relaxation. J Clin Invest 86:1913-1920, 1990
36. LINZ W, SHAPER J, WIEMER G, ALBUS U, SCHÖLKEN S: Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol 107:970-975, 1992
37. DAHLOF B, PENNERT K, HANSSON L: Reversal of left ventricular hypertrophy in hypertensive patients: A meta-analysis of 109 treatment studies. Am J Hypertens 5:95-110, 1992
38. GOREN A, GLASER J, DRUKKER A: Diastolic function in children and adolescents on dialysis and after kidney transplantation: An echocardiographic assessment. Pediatr Nephrol 7:725-728, 1993
39. CLARKSON PBM, WHEELDON NM, MACLEOD C, TENNENT M, MACDONALD TM: Effects of angiotensin II and aldosterone on diastolic function in vivo in normal man. Clin Sci 87:397-401, 1994
40. MACMAHON SW, WILCKEN DEL, MACDONALD GJ: The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients. N Engl J Med 314:334-339, 1986
41. DEVEREUX RB, ROMAN MJ: Hypertensive cardiac hypertrophy: Pathophysiologic and clinical characteristics in Hypertension: Pathophysiology, Diagnosis, and Management (2nd ed), edited by LARAGH JH, BRENNER BM, New York, Raven Press, Ltd., 1995, pp 409-432
42. FISHEL RS, EISENBERG S, SHAI S-Y, REDDEN RA, BERNSTEIN KE, BERK BC: Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 25:343-349, 1995
43. VENTURA HO, LAVIE CJ, MESSERLI FH, VALENTINO V, SMART FW, STAPLETON DD, OCHSNER JL: Cardiovascular adaptation to cyclosporine-induced hypertension. J Hum Hypertens 8:233-237, 1994
44. BERGE KE, BERG K: No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 45:169-174, 1994
45. STUDER R, REINECKE H, MÜLLER B, HOLTZ J, JUST H, DREXLER H: Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction. J Clin Invest 94:301-310, 1994